Veeva Systems stock has surged 33.1% over the past month, yet valuation signals are split, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to roughly 20.4% upside while earnings based multiples suggest the shares are on the expensive side.
- The 33.1% gain over the last month signals a sharp shift in sentiment that raises the bar for what counts as good value.
- Expectations for continued growth in subscription revenue and customer expansion can support current pricing, but any disappointment around sales momentum or contract renewals may weigh heavily on the valuation.
- With a valuation score of 3 out of 6, Veeva Systems presents a mixed picture rather than a clear bargain or clear overvaluation on the broader checks.
The issue now is whether the recent rally in Veeva Systems has already priced in most of the upside that the intrinsic value estimate suggests.
Is Veeva Systems Still Cheap on Cash Flow?
The Discounted Cash Flow (DCF) model here focuses on the cash Veeva Systems can generate for shareholders over time. On the latest twelve month numbers, Veeva Systems produced about $1.64b of free cash flow, and the model assumes that cash flows continue to grow from this base rather than shrink.
On these cash flow projections, the DCF model points to an intrinsic value of about $312 per share. That is roughly 20.4% above the current share price, so the stock screens as undervalued on this measure. Because the Street is currently watching for stronger earnings and revenue in the upcoming Q2 2027 report, any shift in expectations on contract renewals or new wins could affect how quickly the market closes that gap, even if the long term cash flow view remains intact.
Overall, the DCF work suggests Veeva Systems stock appears undervalued relative to what its projected cash flows support.
Our Discounted Cash Flow (DCF) analysis suggests Veeva Systems is undervalued by 20.4%. Track this in your watchlist or portfolio, or discover 48 more high quality undervalued stocks.
Has Veeva Systems Run Too Far on Earnings?
The P/E ratio is a useful cross check for Veeva Systems because earnings are a key focus for investors ahead of the upcoming Q2 2027 report. Veeva Systems currently trades on a P/E of 42.8x, which is above the Healthcare Services industry average of 28.6x and below the peer group average of 54.2x. This places the stock between the broader sector and a tighter set of higher rated peers.
The tailored fair P/E ratio estimate for Veeva Systems is 31.6x based on its business profile and risk factors. That is meaningfully below the current 42.8x P/E. The gap suggests investors are paying a premium versus what this framework flags as a more reasonable multiple, even before considering any impact from future earnings surprises or contract trends.
On this earnings multiple check, Veeva Systems stock screens as overvalued.
See what the numbers say about this price — find out in our valuation breakdown.
The Veeva Systems Narrative: What Would Justify Today's Price?
Simply Wall St Narratives aim to connect Veeva Systems' current valuation puzzle with the specific assumptions that would need to hold on growth, margins and earnings for the stock to be worth materially more or less than today's price. Each Narrative ties a fair value to a clear story about Veeva Systems' potential catalysts and risks, so you can track which version of events is gradually being reflected in the market over time on the Community page.
Community views on Veeva Systems are sharply split, with some seeing a high quality compounder and others arguing expectations already look stretched.
Bull case: 23% undervalued
"Veeva is not simply another cloud-software company selling productivity tools. It has built deeply embedded software across the life-sciences value chain…"
Read the full Bull Case to see why Veeva Systems could be undervalued
Bear case: 50% overvalued
"Despite analysts expecting the underlying business to improve, they seem to believe the market's expectations are too high…"
Read the full Bear Case to see why Veeva Systems could be overvalued
Do you think there's more to the story for Veeva Systems? Head over to our Community to see what others are saying!
The Bottom Line
Veeva Systems now sits between two clear valuation signals. The Discounted Cash Flow (DCF) intrinsic value estimate points to meaningful upside based on projected cash generation, while the market multiple view flags the stock as overvalued on earnings compared with its tailored fair P/E. That split reflects a debate between cash flow strength on one side and rich growth expectations on the other. The key question from here is whether Veeva Systems can sustain subscription growth and renewals at a level that keeps the current earnings multiple from becoming a drag on the share price.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com